🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of the study is to demonstrate superiority of rimonab...
Status
Withdrawn
Location
Sanofi-Aventis Administrative Office
Start Date
2008-09
Trial ID
NCT00754689
Treatments Being Tested
The primary objective is to compare the efficacy of rimonabant 20 mg OD fix...
Status
Completed
Location
Sanofi-Aventis
Start Date
2004-09
Trial ID
NCT00458718
Treatments Being Tested
The primary objective is to demonstrate, after 52 weeks of treatment, the n...
Status
Terminated
Location
Sanofi-Aventis Administrative Office
Start Date
2007-03
Trial ID
NCT00449605
Treatments Being Tested
The primary objective is to show whether rimonabant reduces the risk of a h...
Status
Terminated
Location
Sanofi-Aventis Administrative Office
Start Date
2005-12
Trial ID
NCT00263042
Treatments Being Tested
The objective of the study is to evaluate the effect of Rimonabant 20mg in ...
Status
Terminated
Location
Sanofi-Aventis Administrative Office
Start Date
2006-10
Trial ID
NCT00408148
Treatments Being Tested
The primary objective of this study is to assess the effect of rimonabant o...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2004-05
Trial ID
NCT00481923
Treatments Being Tested
Primary objective: To evaluate the effect of long-term administration of R...
Status
Terminated
Location
Sanofi-Aventis
Start Date
2006-05
Trial ID
NCT00325650
Treatments Being Tested
Background: Rimonabant, a CB1 receptor antagonist, blocks effects of cannab...
Status
Completed
Location
University of Maryland, Baltimore
Start Date
2006-04-16
Trial ID
NCT01041170
Treatments Being Tested
The primary study objective was to assess the efficacy of 2 fixed doses of ...
Status
Completed
Location
Sanofi-Aventis Administrative Office
Start Date
2002-09
Trial ID
NCT00358228
Treatments Being Tested
1\) To examine the efficacy of rimonabant in decreasing weight and metaboli...
Status
Terminated
Location
Baltimore VA Medical Center
Start Date
2007-11
Trial ID
NCT00547118
Treatments Being Tested